Michel Skaf, MD
Cardiovascular Disease · Casper, WYNPI 1821041740
Payments from drug & device makers
Across 268 payments — averaging $56.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$5K
- Actelion Pharmaceuticals US, Inc.$1K
- Merck$869
- Biotronik Inc.$685
- AstraZeneca$354
- plus $2K from 22 others
Across 1 payment — averaging $58.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$59
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $5,069 |
| Boston Scientific | 58 | $5,057 |
| Actelion Pharmaceuticals US, Inc. | 31 | $1,164 |
| Merck | 48 | $869 |
| Biotronik Inc. | 2 | $685 |
| AstraZeneca | 18 | $354 |
| Novartis | 15 | $307 |
| Shockwave Medical, Inc | 1 | $192 |
| Amgen | 8 | $182 |
| Alnylam Pharmaceuticals Inc. | 3 | $159 |
| Abbott | 1 | $155 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $120 |
| Impulse Dynamics (USA) Inc. | 2 | $118 |
| E.r. Squibb & Sons, L.L.C. | 7 | $107 |
| Pfizer | 7 | $103 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $97 |
| Abiomed | 2 | $89 |
| Biosense Webster, Inc. | 2 | $57 |
| Bayer | 3 | $53 |
| Boehringer Ingelheim | 3 | $51 |
| Canon Medical Systems USA, Inc. | 1 | $43 |
| Johnson & Johnson | 2 | $41 |
| Viatris Specialty LLC | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $23 |
| Bardy Diagnostics, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| GE HealthCare | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
How this compares
$15,191 in reported general payments places this provider in the 95th percentile of 22 cardiovascular disease providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Casper
- Robert NovickCasper$4K
- Adrian FlutureCasper$3K
- Allan WicksCasper$1K
- Oleg IvanovCasper$765
- John PickrellCasper$526
- Thomas EdwardsCody$13K
- David GonzalezAfton$6K
- Brian KellyPowell$4K
- Smitha NeerukondaCheyenne$3K
- Michael BrennanSheridan$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.